DRUG-THERAPY OF MAJOR OPPORTUNISTIC INFECTIONS IN HIV-INFECTED PATIENTS

被引:0
|
作者
STEIN, M [1 ]
MAYER, K [1 ]
机构
[1] RHODE ISL HOSP,AIDS HIV CLIN,PROVIDENCE,RI 02902
来源
HOSPITAL FORMULARY | 1991年 / 26卷 / 09期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The major causes of morbidity and mortality for patients infected with HIV are AIDS-defining opportunistic infections. These may be due to a wide range of viruses, bacteria, fungi, or protozoa that take advantage of a compromised immune system. Although earlier diagnoses and advances in chemotherapeutics have increased the life expectancy of AIDS patients, the mortality associated with these opportunistic infections continue to be high. Moreover, many patients experience drug-associated toxicities, some particular to AIDS' effect on host responses. Many drugs have to be given chronically, since the patients generally do not recover immunologic function once they develop AIDS.
引用
收藏
页码:706 / 713
页数:8
相关论文
共 50 条
  • [41] MACROPHAGE FUNCTION IN OPPORTUNISTIC NOCARDIA INFECTIONS COMPLICATING IMMUNOSUPPRESSIVE DRUG-THERAPY
    VICKERMAN, J
    FOLB, PI
    KERAAN, M
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1980, 2 (03): : 220 - 220
  • [42] Prevalence of Opportunistic Infections and Causes of Death among Hospitalized HIV-Infected Patients in Sichuan, China
    Pang, Wenwen
    Shang, Pengcheng
    Li, Qingfeng
    Xu, Jiao
    Bi, Lei
    Zhong, Jing
    Pei, Xiaofang
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2018, 244 (03): : 231 - 242
  • [43] Clinical Course of Opportunistic Infections-Toxoplasmosis and Cytomegalovirus Infection in HIV-Infected Patients in Slovakia
    Simekova, Katarina
    Novakova, Elena
    Rosol'anka, Robert
    Masna, Jana
    Antolova, Daniela
    PATHOGENS, 2019, 8 (04):
  • [44] Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa
    Fenner, Lukas
    Reid, Stewart E.
    Fox, Matthew P.
    Garone, Daniela
    Wellington, Maureen
    Prozesky, Hans
    Zwahlen, Marcel
    Schomaker, Michael
    Wandeler, Gilles
    Kancheya, Nzali
    Boulle, Andrew
    Wood, Robin
    Henostroza, German
    Egger, Matthias
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2013, 18 (02) : 194 - 198
  • [45] Increased risk for opportunistic infections during chemotherapy in HIV-infected patients with Kaposi's sarcoma
    Plettenberg, A
    vanDyk, U
    Stoehr, A
    Albrecht, H
    Stellbrink, HJ
    Berger, J
    Meigel, W
    DERMATOLOGY, 1997, 194 (03) : 234 - 237
  • [46] BACTERIAL-INFECTIONS IN HIV-INFECTED PATIENTS
    BERGER, BJ
    HUSSAIN, F
    ROISTACHER, K
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1994, 8 (02) : 449 - 465
  • [47] Bacterial infections in adult HIV-Infected patients
    Nagappan, V
    Kazanjian, P
    HIV CLINICAL TRIALS, 2005, 6 (04): : 213 - 228
  • [48] Management of cmv infections in HIV-infected patients
    Hoy, J
    ANTIVIRAL CHEMOTHERAPY 5: NEW DIRECTIONS FOR CLINICAL APPLICATION AND RESEARCH, 1999, 458 : 77 - 87
  • [49] Treatment of VZV infections in HIV-infected patients
    Breton, G
    Bricaire, F
    Caumes, E
    PRESSE MEDICALE, 1999, 28 (28): : 1518 - 1518
  • [50] Nosocomial infections in HIV-infected/AIDS patients
    Duse, AG
    JOURNAL OF HOSPITAL INFECTION, 1999, 43 : S191 - S201